Footwear and Injury Prevention Study
|ClinicalTrials.gov Identifier: NCT00832195|
Recruitment Status : Completed
First Posted : January 30, 2009
Last Update Posted : February 19, 2014
|Condition or disease||Intervention/treatment||Phase|
|Pronation Control||Device: Motion Controlling Running Shoe Device: Neutral Running Shoe||Phase 3|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||103 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Footwear Prevention Study: Investigating the Effects of Running Shoe Pronation Control on the Risk of Injury|
|Study Start Date :||March 2009|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2009|
Footwear with motion controlling elements built into construction in order to reduce pronation of the foot and ankle during running.
Device: Motion Controlling Running Shoe
Running shoe with thermoplastic mid-foot shank stiffener, denser durometer foam on medial aspect of mid-sole, reinforced heel counter, wider sole-plate, and lateral foam crash-pad.
Active Comparator: 2
Footwear with standard neutral stabilization elements for the foot and ankle during running.
Device: Neutral Running Shoe
Standard running shoe with single density mid-sole foam.
- Injury status, as measured at baseline, 6 weeks, and at the end of the 13-week programme [ Time Frame: 13 weeks ]
- Pain levels, as measured at baseline, 6 weeks, and at the end of the 13-week programme [ Time Frame: 13 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00832195
|Canada, British Columbia|
|Vancouver, British Columbia, Canada|
|Principal Investigator:||Jack Taunton, MD||University of British Columbia|
|Study Director:||Michael Ryan||University of British Columbia|